Enforcement Experts: COVID-19 Backlog Could Last Years

 
• By Elizabeth Orr

The US Department of Justice faces significant challenges in investigating and punishing bad behavior during the COVID-19 pandemic, attorneys say.

Street sign reading "Expect Delays"

The US Department of Justice may be investigating and punishing bad behavior that occurred during the COVID-19 pandemic for years to come, a panel of King & Spalding attorneys said on 10 November during the law firm’s 13th Annual Medical Device Summit.

The core areas where device companies face enforcement action have remained remarkably steady over the years, with anti-kickback violations at...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Compliance

More from Policy & Regulation

Increasing Safety Concerns Spur Scrutiny of Device Plastics Use

 
• By Elizabeth Orr

With new regulations limiting the use of plastics popping up worldwide, the medtech industry sees arguments on both sides. Some argue hasty bans of PFAS ("forever chemicals") would harm patients, while others say phthalates should be phased out to protect the public.

With LDT Rule DOA, Could FDA Shift Focus To RUOs?

 
• By Brian Bossetta

Now that the US FDA has chosen not to appeal a March ruling effectively killing the agency’s efforts to regulate lab-developed tests as medical devices, will the agency adopt a different strategy to flex its regulatory muscle?

US FDA Unveils Plans To Consolidate Support Services

 
• By Derrick Gingery and Sue Sutter

Commissioner Martin Makary told staff that plans are being developed to centralize HR, IT, travel and other functions, which were heavily impacted by the 1 April reduction-in-force.